Bacteriophage Market Analysis: To Reach Around US$ 567.9 Mn In 2027

The global bacteriophage market was valued at US$ 567.9 Mn in 2017 expanding at a CAGR of 3.9% from 2018 to 2026.

Market Insights

Recently, bacteriophages or phages have been recognized as an efficient tool in modern biotechnology through a multitude of researches promoting the potential use of bacteriophages across a number of applications. Researchers have also proposed bacteriophages as a viable alternative to antibiotics for a number of antibiotic-resistant bacterial strains. They can also be used as biocontrol agents in the oil and agriculture industries.

Bacteriophages have a unique application in the petroleum industry, as bacterial fouling often leads to serious damage to gas pipelines, devaluing products and therefore increasing capital costs. In addition, bacteriophages may also be used as vaccine vehicles, for the detection of pathogenic bacterial strain, and as display systems (phage displays) for several antibodies and proteins. Bacteriophages are a diverse group of viruses that can be easily manipulated and therefore have a significant role to play in research, therapeutics and biotechnology.

Phages not only control the bacterial population, but also help to move genes from one bacterium to another. The Bacteriophage Particle Study therefore provides insights into genome evolution, bacterial evolution, DNA expression and copying, and thus the development of new biotechnology. Globally, the incessant increase in bacterial resistance to most antibiotics is becoming a new driving factor for phage therapy that uses lytic phage particles because these entities are devoid of metabolic functioning and do not have an affinity to eukaryotic cells. In addition, the use of bacteriophage particles in phage vaccination is also emerging as one of the promising preventive strategies currently under investigation. Bacteriophageal biosensing devices, phage-display based selection of biological affinity molecules, food biopreservation, food safety, biocontrol of plant pathogens, corrosion control and biofilm control are also key areas for renewed focus.

Get Sample Copy of This Report With Covid19 Impact Analysis:

Considering the product types, global bacteriophage market categorized into ssDNA (single strand DNA) bacteriophage, dsDNA (double strand DNA) bacteriophage and ssRNA (single strand RNA) bacteriophage. In 2017, dsDNA bacteriophage occupied largest share in the global market, and anticipated to continue its lead throughout the forecast period from 2018 to 2026. Majority of the cultivated viruses that have potential in culminating the widest range of bacteria are dsDNA, therefore dominating the global market. dsDNA bacteriophage also have a wide applicability in phage display technologies.

In terms of geography, North America held the largest share in the global bacteriophage market due to prominent phage entities in the U.S., faster and first in the world commercialization process in the region, and significantly large patient pool suffering with bacterial infections and growing incidence of anti-biotic resistance. Moreover, established use of bacteriophages in the areas of environment and food and evolved research infrastructure with several initiatives being undertaken introducing breakthrough technologies will further drive the market during the forecast period. Asia Pacific is projected to witness the fastest progress in the global market due to rapidly evolving biotechnology infrastructure, evolving agriculture practices, and equally supportive government initiatives. The key players currently engaged in bacteriophage market include Federal State Scientific Industrial Company MICROGEN, AmpliPhi Biosciences Corporation, EnBiotix, Phage Biotech Ltd., Fixed-Phage Limited, InnoPhage, Pherecydes Pharma, TechnoPhage SA, VersatileBio among others.

Key Market Movements:

  • Growing R&D and funding for investigating bacteriophage therapy for clinical application
    • Ongoing clinical trials for bacteriophage therapy for multidrug resistant bacterial infections and regulatory approvals for the same
    • Increasing applications of bacteriophage in food, environment and veterinary applications
    • Ongoing research for establishing bacteriophage as an effective vaccine delivery system

Get Sample Copy of This Report With Covid19 Impact Analysis:


Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Bacteriophage Market Portraiture
2.2. Global Bacteriophage Market, by Product Type, 2017 (US$ Mn)
2.3. Global Bacteriophage Market, by Application, 2017 (US$ Mn)
2.4. Global Bacteriophage Market, by Geography, 2017 (US$ Mn)

Chapter 3. Bacteriophage: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Widening Application of Bacteriophages
3.2.2. Renewed Interest in Phage Therapy
3.3. Challenges
3.3.1. Significant Regulatory Challenges for Approval as an Alternative to Antibiotics
3.4. Opportunities
3.4.1. Phage Particles as Vaccine Carriers
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Bacteriophage Market, by Key Players, 2017

Chapter 4. Global Bacteriophage Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. dsDNA Bacteriophage
4.3. ssDNA Bacteriophage
4.4. ssRNA BActeriophage

Chapter 5. Global Bacteriophage Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Clinical Application
5.3. Food & Beverages
5.4. Phage Display
5.5. Phage Therapy
5.6. Environmental Application
5.7. Veterinary

Chapter 6. Global Bacteriophage Market, by Geography, 2016 – 2026 (US$ Mn)

Chapter 7. Company Profiles

Get Sample Copy of This Report With Covid19 Impact Analysis:


About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
(US/CANADA) Ph.: +1-800-361-8290